greeksoup/ stock research

UnitedHealth Group (UNH) Q2 FY2026 earnings: revenue $112.0 billion, up 0.4% on the year

UnitedHealth Group Inc. (UNH) reported revenue of $112.0 billion for Q2 FY2026, the quarter ended 30 June 2026, up 0.4% on the same quarter a year earlier. Net income was $5.5 billion, up 61.0% on the year, and diluted earnings per share $6.04. The figures are the company's own, from the 10-Q it filed with the SEC on 10 August 2026.

Revenue
$112.0 billion
+0.4% on the year · +0.3% on the quarter
Q3 FY2024Q2 FY2026
Operating margin
7.1%
4.6% a year earlier
Q3 FY2024Q2 FY2026
Net income
$5.5 billion
+61.0% on the year · -12.7% on the quarter
Q3 FY2024Q2 FY2026
Diluted EPS
$6.04
+61.5% on the year · -12.5% on the quarter
Q3 FY2024Q2 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

What management said

Guidance figures: 10 raised, 2 lowered, 2 kept.

  • Earnings per share rose year over year: Diluted EPS was $6.04 against $3.74 a year earlier; adjusted EPS was $6.38 against $4.08. Earnings from operations were $8.0 billion against $5.2 billion, with a 4.9% net margin.
  • Full-year EPS guidance raised: The full-year diluted EPS range is now $18.45 to $18.95 and adjusted EPS $19.50 to $20.00, up from greater than $17.35 and $18.25 in the April release.
  • UnitedHealthcare margin rose to 4.6%: UnitedHealthcare earnings from operations were $3.9 billion on revenues of $86.0 billion, after $5.7 billion and a 6.6% margin in the first quarter.
Read the earnings call summary

Income statement (profit and loss)

$ millionQ2 FY2026Q1 FY2026Q2 FY2025On the quarterOn the yearLast 8 quarters
Revenue112,032111,721111,616+0.3%+0.4%
Cost of revenue13,37512,82313,019+4.3%+2.7%
Gross profit98,65798,89898,597-0.2%+0.1%
Gross margin88.1%88.5%88.3%
Selling, general and administrative14,26815,39013,778-7.3%+3.6%
Operating income7,9918,9905,150-11.1%+55.2%
Operating margin7.1%8.0%4.6%
Interest expense9629551,027+0.7%-6.3%
Pre-tax income6,9687,9634,082-12.5%+70.7%
Income tax1,2981,482510-12.4%+154.5%
Effective tax rate18.6%18.6%12.5%
Net income5,4846,2803,406-12.7%+61.0%
Net margin4.9%5.6%3.1%
Diluted EPS$6.04$6.90$3.74-12.5%+61.5%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ2 FY2026Q1 FY2026Q2 FY2025On the quarterOn the yearLast 8 quarters
Operating cash flow11,0528,9127,188+24.0%+53.8%
Capital expenditure799763886+4.7%-9.8%
Free cash flow10,2538,1496,302+25.8%+62.7%
Free cash flow margin9.2%7.3%5.6%
Cash from investing-1,798-2,447-1,442
Cash from financing-8,623-2,992-7,947
Depreciation and amortisation1,0401,0291,084+1.1%-4.1%
Share-based compensation276348197-20.7%+40.1%
Buybacks1,6460.02,545-35.3%
Dividends paid2,0872,0052,000+4.1%+4.3%
Dividend per share$2.32$2.21$2.21+5.0%+5.0%
Diluted shares, weighted906m910m910m-0.4%-0.4%
Shares outstanding at period end905m908m905m-0.3%0.0%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ2 FY2026Q1 FY2026Q2 FY2025On the quarterOn the yearLast 8 quarters
Shareholders' equity104,513103,895100,469+0.6%+4.0%
Redeemable equity1,4361,4244,315+0.8%-66.7%
Debt73,32877,91779,193-5.9%-7.4%
Other liabilities130,450129,408124,596+0.8%+4.7%
Total liabilities and equity309,727312,644308,573-0.9%+0.4%
Fixed assets10,76210,66710,923+0.9%-1.5%
Goodwill110,645110,512107,677+0.1%+2.8%
Intangible assets19,74920,09322,510-1.7%-12.3%
Investments60,59960,01655,890+1.0%+8.4%
Cash and equivalents28,58528,00128,596+2.1%-0.0%
Receivables21,57326,58724,142-18.9%-10.6%
Other assets57,81456,76858,835+1.8%-1.7%
Total assets309,727312,644308,573-0.9%+0.4%

Questions

What was UnitedHealth Group's revenue in Q2 FY2026?

UnitedHealth Group (UNH) reported revenue of $112.0 billion for Q2 FY2026, the quarter ended 30 June 2026, up 0.4% on the same quarter a year earlier.

How much did UnitedHealth Group earn in Q2 FY2026?

Net income for Q2 FY2026 was $5.5 billion, up 61.0% on the year, and diluted earnings per share $6.04.

When did UnitedHealth Group report Q2 FY2026 results?

UnitedHealth Group filed its 10-Q for the quarter ended 30 June 2026 with the SEC on 10 August 2026.

Quarterly results, the last 20 quarters

Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue73,74380,14980,33280,89482,78791,93192,90392,36194,42799,79698,855100,820100,807109,575111,616113,161113,215111,721112,032112,694
Cost of revenue8,0008,4878,5968,3068,3149,4059,7489,42310,19411,05611,34011,83412,46412,39013,01912,56612,68012,82313,37513,707
Gross profit65,74371,66271,73672,58874,47382,52683,15582,93884,23388,74087,51588,98688,34397,18598,597100,595100,53598,89898,65798,987
Gross margin89%89%89%90%90%90%90%90%89%89%89%88%88%89%88%89%89%89%88%88%
SG&A11,27211,40111,70911,66313,00913,62513,80913,85513,33914,07713,16213,28012,49413,59413,77815,22316,99715,39014,26814,369
Operating income5,5416,9507,1327,4626,8918,0868,0578,5267,6897,9317,8758,7087,7739,1195,1504,3153808,9907,9916,563
Operating margin8%9%9%9%8%9%9%9%8%8%8%9%8%8%5%4%0%8%7%6%
Interest expense4314334675166767548288348308449851,0741,0039981,0271,003974955962963
Pre-tax income5,1106,5176,6656,9466,2157,3327,2297,6926,8591.05,6657,6146,7918,1064,0823,229-7207,9636,9685,524
Tax rate18%21%22%22%21%21%22%22%17%122200%22%18%15%20%12%21%n/a19%19%22%
Net income4,0715,0275,0705,2624,7615,6115,4745,8415,455-1,4094,2166,0555,5436,2923,4062,34810.06,2805,4844,110
Net margin6%6%6%7%6%6%6%6%6%-1%4%6%5%6%3%2%0%6%5%4%
Diluted EPS$4.26$5.27$5.34$5.55$5.03$5.95$5.82$6.24$5.83-$1.53$4.54$6.51$5.98$6.85$3.74$2.59$0.01$6.90$6.04$4.56
Operating cash flow3,2185,3196,87118,549-4,53316,32711,0326,902-5,1931,1446,74613,9452,3695,4567,1885,9451,1088,91211,0525,123
Capital expenditure695555657724866760829838959743853991912898886890948763799859
Free cash flow2,5234,7646,21417,825-5,39915,56710,2036,064-6,1524015,89312,9541,4574,5586,3025,0551608,14910,2534,264
Buybacks1,0502,5002,5001,0001,0002,0003,0001,5001,5003,0720.09564,9723,0002,5450.00.00.01,6463,385
Dividends paid1,3651,3631,5451,5421,5411,5371,7471,7391,7381,7291,9351,9371,9321,9122,0002,0022,0022,0052,0872,078
Shares outstanding941m939m935m935m934m932m927m925m924m920m921m923m915m910m905m906m906m908m905m896m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 30 June 2026, filed 10 August 2026: the filing.